U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904287) titled 'Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines' on March 24.
Brief Summary: The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Migraine
Intervention:
DRUG: Magnesium
Prochlorperazine 10 mg administered as an intravenous push over 2 minutes followed by magnesium 2 g administered as an intravenous bolus over a period of 20 minutes
DRUG: Placebo
Prochlorperazine 10 mg administered as an intravenous push over 2 minutes followed by pl...